" /> Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s - CISMeF





Preferred Label : Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s;

NCIt synonyms : Autologous Anti-CD22 CAR T-Cells CART22-65s; Autologous CART22-65s Cells; Autologous CART22-65s T-cells; Autologous Anti-CD22 scFv CAR 4-1BB-TCRz-expressing T-lymphocytes CART22-65s; Autologous CART22-65s-expressing T-cells;

NCIt definition : Autologous human T-lymphocytes transduced with a recombinant lentiviral vector encoding a chimeric antigen receptor (CAR) consisting of an anti-CD22 human single chain variable fragment (scFv) and linked to the co-stimulatory domain 4-1BB (CD137) coupled to the zeta chain of the TCR/CD3 complex (CD3-zeta), with potential immunostimulating and antineoplastic activities. Upon reintroduction into the patient, the autologous anti-CD22 CAR-4-1BB-TCRz -transduced T-lymphocytes CART22-65s express anti-CD22-CAR on their cell surfaces and bind to the CD22 antigen on tumor cell surfaces, resulting in lysis of CD22-expressing tumor cells. CD22, a B-lineage-restricted, transmembrane phosphoglycoprotein, is expressed on malignant B-cells.;

Molecule name : CART22-65s;

NCI Metathesaurus CUI : CL562955;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.